Stifel analysts increased their price target for Zimmer Biomet Holdings Inc (NYSE:ZBH) shares from $130.00 to $138.00, while reiterating a Buy rating on the stock. The firm expressed confidence in the ...
Stifel Financial Corp. (NYSE: SF) will release its fourth quarter and full year 2024 financial results before the market ...
Fintel reports that on January 22, 2025, Stifel initiated coverage of Edgewise Therapeutics (NasdaqGS:EWTX) with a Hold ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback